These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19956881)

  • 1. CpG island methylation of BNIP3 predicts resistance against S-1/CPT-11 combined therapy in colorectal cancer patients.
    Hiraki M; Kitajima Y; Nakafusa Y; Nakamura J; Hashiguchi K; Sumi K; Noshiro H; Miyazaki K
    Oncol Rep; 2010 Jan; 23(1):191-7. PubMed ID: 19956881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
    Murai M; Toyota M; Suzuki H; Satoh A; Sasaki Y; Akino K; Ueno M; Takahashi F; Kusano M; Mita H; Yanagihara K; Endo T; Hinoda Y; Tokino T; Imai K
    Clin Cancer Res; 2005 Feb; 11(3):1021-7. PubMed ID: 15709167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.
    Sugita H; Iida S; Inokuchi M; Kato K; Ishiguro M; Ishikawa T; Takagi Y; Enjoji M; Yamada H; Uetake H; Kojima K; Sugihara K
    Oncol Rep; 2011 Feb; 25(2):513-8. PubMed ID: 21152877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation of CHFR is not a predictor of the response to docetaxel and paclitaxel in advanced and recurrent gastric cancer.
    Yoshida K; Hamai Y; Suzuki T; Sanada Y; Oue N; Yasui W
    Anticancer Res; 2006; 26(1A):49-54. PubMed ID: 16475678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma.
    Ogino S; Meyerhardt JA; Kawasaki T; Clark JW; Ryan DP; Kulke MH; Enzinger PC; Wolpin BM; Loda M; Fuchs CS
    Virchows Arch; 2007 May; 450(5):529-37. PubMed ID: 17372756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Second-or third-line chemotherapy with CPT-11+TS-1 for 5 cases of metastatic and recurrent colorectal cancer].
    Ogata K; Ohchi T; Doi K; Matsuo A; Kudo K; Ootao R
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):627-30. PubMed ID: 17431354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combined therapy with low-dose 5-aza-2'-deoxycytidine and irinotecan on colon cancer cell line HCT-15.
    Ishiguro M; Iida S; Uetake H; Morita S; Makino H; Kato K; Takagi Y; Enomoto M; Sugihara K
    Ann Surg Oncol; 2007 May; 14(5):1752-62. PubMed ID: 17195906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of UGT1A1 gene methylation level in colorectal cancer cells on the sensitivity of the chemotherapy drug CPT-11.
    Xie FW; Peng YH; Wang WW; Chen X; Chen X; Li J; Yu ZY; Ouyang XN
    Biomed Pharmacother; 2014 Sep; 68(7):825-31. PubMed ID: 25260839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
    Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
    Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a potent epigenetic biomarker for resistance to camptothecin and poor outcome to irinotecan-based chemotherapy in colon cancer.
    Miyaki Y; Suzuki K; Koizumi K; Kato T; Saito M; Kamiyama H; Maeda T; Shibata K; Shiya N; Konishi F
    Int J Oncol; 2012 Jan; 40(1):217-26. PubMed ID: 21901246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interplay between epigenetic silencing, oncogenic KRas and HIF-1 regulatory pathways in control of BNIP3 expression in human colorectal cancer cells.
    Swiderek E; Kalas W; Wysokinska E; Pawlak A; Rak J; Strzadala L
    Biochem Biophys Res Commun; 2013 Nov; 441(4):707-12. PubMed ID: 24211581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination chemotherapy with S-1 plus CPT-11 for patients with advanced or recurrent colorectal cancer].
    Tsunoda A; Nakao K; Kamiyama G; Narita K; Yamazaki K; Watanabe M; Suzuki N; Oonaka T; Kusano M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():135-7. PubMed ID: 16897989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I trial of CPT-11 and S-1 combination chemotherapy in patients with metastatic colorectal cancer.
    Yamaguchi Y; Minami K; Kawabuchi Y; Ohshita A; Hironaka K
    Hepatogastroenterology; 2008; 55(82-83):407-11. PubMed ID: 18613376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [S-1 as a single agent for colorectal cancer].
    Eguchi T; Shirao K
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():121-4. PubMed ID: 16897986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effects of Hange-shashin-to on combination therapy of S-1/irinotecan against the for patients with metastatic gastric and colorectal cancer].
    Hibi S; Ina K; Furuta R; Kataoka T; Kojima S; Kawai M
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1485-8. PubMed ID: 19755817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer.
    Cha Y; Kim SY; Yeo HY; Baek JY; Choi MK; Jung KH; Dong SM; Chang HJ
    Neoplasia; 2019 Jan; 21(1):146-155. PubMed ID: 30562637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose chemotherapy with leucovorin plus 5-fluorouracil for colorectal cancer can maintain host immunity.
    Kobayashi R; Yoshimatsu K; Yokomizo H; Katsube T; Ogawa K
    Anticancer Res; 2007; 27(1B):675-9. PubMed ID: 17348459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer.
    Tsunoda A; Yasuda N; Nakao K; Narita K; Yamazaki K; Watanabe M; Suzuki N; Kusano M
    Oncology; 2007; 72(1-2):58-63. PubMed ID: 17998791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours.
    Murai M; Toyota M; Satoh A; Suzuki H; Akino K; Mita H; Sasaki Y; Ishida T; Shen L; Garcia-Manero G; Issa JP; Hinoda Y; Tokino T; Imai K
    Br J Cancer; 2005 Mar; 92(6):1165-72. PubMed ID: 15756280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.